| Name | Retagliptin Phosphate |
|---|---|
| Synonyms |
Retagliptin Phosphate, 10 mM in DMSO
24NZ3UE3DJ Methyl 7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-carboxylate phosphate (1:1) Imidazo[1,5-a]pyrazine-1-carboxylic acid, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-, methyl ester, phosphate (1:1) RetagliptinPhosphate (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- cboxylic acid methyl ester RETAGLIPTIN; SP-2086 Reagliptin (phosphate) DA1089 SP-2086,Retagliptin Phosphate,DPP-4,SP2086,inhibit,GLP-1,T2DM,Retagliptin,DPP,Inhibitor,Diptidyl Ptidase Triazolam Impurity 8 SP-2086 methyl (R)-7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-cboxylate phosphate |
| Description | Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor for treating type-2 diabetes. |
|---|---|
| Related Catalog | |
| Target |
DPP-4[1]. |
| References |
| Molecular Formula | C19H21F6N4O7P |
|---|---|
| Molecular Weight | 562.357 |
| Exact Mass | 562.105225 |
| Storage condition | 2-8℃ |